跳至主要内容
临床试验/CTRI/2021/12/038468
CTRI/2021/12/038468尚未招募未知

Open labelled, randomized, controlled trial of romiplostim for reducing rejection and platelet transfusions in autologous and allogeneic hematopoietic stem cell transplantation (HSCT) and High dose chemotherapy.

Dr Sachin Suresh Jadhav0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方